Liver fibrosis and its response to avapritinib in 2 patients with systemic mastocytosis-Reference-Cited by-同舟云学术

Liver fibrosis and its response to avapritinib in 2 patients with systemic mastocytosis

Published:2022-10-18 Issue:20 Volume:6 Page:5630-5633
ISSN:2473-9529
Container-title:Blood Advances
language:en
Short-container-title:

Author:

Cavazos Karla¹,Eswaran Sheila²,Maidlow Cathleen¹,Keklik Karadag Fatma³^ORCID,Idilman Ramazan⁴^ORCID,Idilman Ilkay⁵^ORCID,Miller Ira⁶,Shammo Jamile¹,Reau Nancy²,Ustun Celalettin¹^ORCID

Affiliation:

1. 1Division of Hematology, Oncology, and Cellular Therapy, Department of Medicine, Rush University Medical Center, Chicago, IL

2. 2Division of Gastroenterology, Hepatology, and Nutrition, Rush University Medical Center, Chicago, IL

3. 3Division of Hematology, Department of Medicine, Ege University, Izmir, Turkey

4. 4Division of Gastroenterology, Department of Medicine, Ankara University, Ankara, Turkey

5. 5Department of Radiology, Hacettepe University, Ankara, Turkey

6. 6Department of Pathology, Rush University Medical Center, Chicago, IL

Publisher

American Society of Hematology

Subject

Hematology

Link

https://ashpublications.org/bloodadvances/article-pdf/6/20/5630/1925296/blooda_adv-2022-008038-main.pdf

Reference25 articles.

1. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia;Arber;Blood,2016

2. Updated diagnostic criteria and classification of mast cell disorders: a consensus proposal;Valent;HemaSphere,2021

3. Standards and standardization in mastocytosis: consensus statements on diagnostics, treatment recommendations and response criteria;Valent;Eur J Clin Invest,2007

4. Gastrointestinal manifestations in mastocytosis: a study of 83 patients;Sokol;J Allergy Clin Immunol,2013

5. Systemic mastocytosis: multidisciplinary approach;Zanotti;Mediterr J Hematol Infect Dis,2021